Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Gains from Sales and Divestitures (2018 - 2022)

Kiora Pharmaceuticals' Gains from Sales and Divestitures history spans 5 years, with the latest figure at $246.0 for Q3 2022.

  • For Q3 2022, Gains from Sales and Divestitures fell 5.38% year-over-year to $246.0; the TTM value through Sep 2022 reached $246.0, down 5.38%, while the annual FY2021 figure was $46437.0, 2.25% up from the prior year.
  • Gains from Sales and Divestitures reached $246.0 in Q3 2022 per KPRX's latest filing, down from $9781.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $227875.0 in Q3 2018 to a low of $246.0 in Q3 2022.
  • Average Gains from Sales and Divestitures over 5 years is $32956.4, with a median of $13219.5 recorded in 2020.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 1432.56% in 2019, then crashed 98.91% in 2021.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $4152.0 in 2018, then skyrocketed by 1432.56% to $63632.0 in 2019, then decreased by 28.63% to $45417.0 in 2020, then increased by 2.25% to $46437.0 in 2021, then tumbled by 99.47% to $246.0 in 2022.
  • Per Business Quant, the three most recent readings for KPRX's Gains from Sales and Divestitures are $246.0 (Q3 2022), $9781.0 (Q2 2022), and $9079.0 (Q1 2022).